Singular Genomics Stock Forecast - Maximum Drawdown

OMIC Stock  USD 0.40  0.01  2.56%   
Singular Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Singular Genomics stock prices and determine the direction of Singular Genomics Systems's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Singular Genomics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Singular Genomics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Singular Genomics' systematic risk associated with finding meaningful patterns of Singular Genomics fundamentals over time.
Check out Historical Fundamental Analysis of Singular Genomics to cross-verify your projections.
  
At present, Singular Genomics' Asset Turnover is projected to increase slightly based on the last few years of reporting. . The current year's Common Stock Shares Outstanding is expected to grow to about 78.1 M, whereas Net Loss is forecasted to decline to (85.9 M).

Open Interest Against 2024-04-19 Singular Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Singular Genomics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Singular Genomics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Singular Genomics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Singular Genomics' open interest, investors have to compare it to Singular Genomics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Singular Genomics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Singular. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Singular Genomics Systems has current Maximum Drawdown of 0.
Most investors in Singular Genomics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Singular Genomics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Singular Genomics' price structures and extracts relationships that further increase the generated results' accuracy.
Check Singular Genomics VolatilityBacktest Singular GenomicsInformation Ratio  

Singular Genomics Trading Date Momentum

On April 19 2024 Singular Genomics Systems was traded for  0.40  at the closing time. The top price for the day was 0.41  and the lowest listed price was  0.38 . The trading volume for the day was 119.3 K. The trading history from April 19, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 2.50% .
Compare Singular Genomics to competition

Other Forecasting Options for Singular Genomics

For every potential investor in Singular, whether a beginner or expert, Singular Genomics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Singular Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Singular. Basic forecasting techniques help filter out the noise by identifying Singular Genomics' price trends.

Singular Genomics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Singular Genomics stock to make a market-neutral strategy. Peer analysis of Singular Genomics could also be used in its relative valuation, which is a method of valuing Singular Genomics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Singular Genomics Systems Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Singular Genomics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Singular Genomics' current price.

Singular Genomics Market Strength Events

Market strength indicators help investors to evaluate how Singular Genomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Singular Genomics shares will generate the highest return on investment. By undertsting and applying Singular Genomics stock market strength indicators, traders can identify Singular Genomics Systems entry and exit signals to maximize returns.

Singular Genomics Risk Indicators

The analysis of Singular Genomics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Singular Genomics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting singular stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Singular Genomics Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Singular Genomics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Singular Genomics Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Singular Genomics Systems Stock:
Check out Historical Fundamental Analysis of Singular Genomics to cross-verify your projections.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Singular Stock analysis

When running Singular Genomics' price analysis, check to measure Singular Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Singular Genomics is operating at the current time. Most of Singular Genomics' value examination focuses on studying past and present price action to predict the probability of Singular Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Singular Genomics' price. Additionally, you may evaluate how the addition of Singular Genomics to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Is Singular Genomics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Singular Genomics. If investors know Singular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Singular Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.30)
Revenue Per Share
0.04
Quarterly Revenue Growth
0.413
Return On Assets
(0.21)
Return On Equity
(0.43)
The market value of Singular Genomics Systems is measured differently than its book value, which is the value of Singular that is recorded on the company's balance sheet. Investors also form their own opinion of Singular Genomics' value that differs from its market value or its book value, called intrinsic value, which is Singular Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Singular Genomics' market value can be influenced by many factors that don't directly affect Singular Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Singular Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Singular Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Singular Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.